Holos Integrated Wealth
ABBV icon

Holos Integrated Wealth’s AbbVie ABBV Stock Holding History

Holos Integrated Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$313K Buy
1,107
+203
+22% +$52K 0.14% 63
2026
Q2 		$230K Hold
904
– – 0.11% 76
2026
Q1 		$187K Hold
904
– – 0.09% 92
2025
Q4 		$207K Buy
904
+73
+9% +$16.6K 0.12% 68
2025
Q3 		$191K Hold
831
– – 0.11% 66
2025
Q2 		$164K Sell
831
-72
-8% -$13.4K 0.1% 70
2025
Q1 		$189K Hold
903
– – 0.12% 67
2024
Q4 		$161K Buy
+903
New +$166K 0.11% 60

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Holos Integrated Wealth's ABBV Position: Q3 2026 in Review

Holos Integrated Wealth increased its AbbVie (ABBV) stake by 22% in Q3 2026, buying an estimated $52K and bringing the position to 1,107 shares worth $313K. The position accounts for 0.14% of the portfolio, ranked #63.

Holos Integrated Wealth first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Holos Integrated Wealth held 1,107 shares of AbbVie worth $313K as of Q3 2026.
  • Holos Integrated Wealth bought 203 AbbVie shares in Q3 2026, an estimated $52K.
  • AbbVie made up 0.14% of Holos Integrated Wealth's portfolio in Q3 2026, its #63 holding.
  • Holos Integrated Wealth first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Holos Integrated Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.